Insider
New twists at Nexbis add to bafflement
Insider If you're owed money by a mate with neither assets nor a steady income you have two choices: either write off the debt, or find a way to help get some funds into his pocket so that he can repay you.
Nufarm in a club no one wants to join
Insider The agricultural chemicals company Nufarm yesterday joined a small, but ignominious, group of companies required by the ASX to explain the timing of disappointing profit result releases.
Hold the diagnosis: Sigma delays update
Insider Sigma Pharmaceuticals is keeping the market waiting for an update on earnings for the year to January.
Between a rock and a Caterpillar importer
Insider Seven Network shareholders will be asked to choose between two dud options when the scheme documents for the WesTrac acquisition are distributed in coming weeks.
Big Dick knows when to fold 'em and hold 'em, too
Insider Scouring the history books provides a few clues to the likely bidding strategy of the NSW Lotteries auction front-runner, Tatts Group, as interested parties prepare to lodge final bids early next...
Poor arithmetic to hurt Prime Infrastructure
Insider November equity raising of $1.8 billion has not reversed negative market sentiment towards Prime Infrastructure, the recently rebadged Babcock & Brown Infrastructure.
Healthscope deal was a non-starter
Insider The role that investment banking advisors played in Healthscope's botched efforts to acquire aged-care operator Arcare is one of the untold chapters in this sorry tale.
Europe sneezes, Biota cheers
Insider In good news for Biota shareholders, GlaxoSmithKline reported overnight that flu anti-viral Relenza was a major contributor to the pharmaceutical giant's December quarter performance.
Future Fund consortium leads the property charge
Insider Bids for the $1 billion-plus sale of the unlisted ING Retail Property Fund were lodged yesterday, and a consortium comprising Lend Lease's wholesale property fund and the Government's Future Fund is...
CuDeco explores buybacks
Insider Queensland copper hopeful CuDeco is never short of head-turning moves.
Sinochem waits in wings at Nufarm
Insider It has been more than two months since Nufarm revealed it was in takeover talks with China's Sinochem, and there has been little in the way of an update since.
Will CanWest start a cascade?
Insider There is sure to be speculation that Independent News & Media could sell down its stake in APN News & Media.
Telstra's Future Fund risk
Insider In light of all of the uncertainty surrounding the future of Telstra, it is perhaps not surprising that a prospectus for its annual debt issuance program lodged in the UK lists plenty of risk factors.
Defence blocks Chinese bid
Insider The Department of Defence has rejected a second bid for a Chinese state-owned company to take a stake in a project located in the Woomera Prohibited Area.
LPTs face currency hit
Insider Analysts fear currency effects on property trusts, calculation errors force Harvey Norman to refile accounts, plus the return of the raiders.
Confidence boost for Westfield
Insider Plus, Mac Media mulls an equity raising, and Aussie buyers seen keen on UK asset fire sale.
A stunning jewel in Babcock's portfolio
Insider It often pays to read the fine print. But with the reams of documentation surrounding Babcock & Brown Infrastructure's complex $1.
Billabong rides the crest
Insider It has been quite a while since analysts argued exposure to the US economy was a good reason to buy a stock.
Updates loom but dollar dampens mood
Insider There are plenty of annual meetings scheduled for the tail-end of this month - and investors will want trading updates.
Alcoa surprise sets the ball rolling
Insider The third-quarter earnings season in the US officially kicks off this morning as Alcoa releases its latest results.
